Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Bladder Cancer

Free Subscription Articles published in Urol Int Retrieve available abstracts of 48 articles: HTML format Text format

Single Articles

January 2012
1. CERULLI C , Busetto GM, Antonini G, Giovannone R, et al
   Primary Metastatic Neuroendocrine Small Cell Bladder Cancer: A Case Report and Literature Review.
   Urol Int. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
2. LI D , Liu H, Yan L, Tang Y, et al
   Lack of Association between hOGG1 Ser326Cys Polymorphism and the Risk of Bladder Cancer: A Meta-Analysis.
   Urol Int. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
3. BRAUSI MA , Gontero P, Altieri V, Colombo R, et al
   Can Gemcitabine Instillation Ablate Solitary Low-Risk Non-Muscle-Invasive Bladder Cancer? Results of a Phase II Marker Lesion Study.
   Urol Int. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   August 2011
4. SHAPUR N , Pode D, Katz R, Shapiro A, et al
   Predicting the Risk of High-Grade Bladder Cancer Using Noninvasive Data.
   Urol Int. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   May 2011
5. WU D , Tao J, Xu B, Qing W, et al
   Phosphatidylinositol 3-Kinase Inhibitor LY294002 Suppresses Proliferation and Sensitizes Doxorubicin Chemotherapy in Bladder Cancer Cells.
   Urol Int. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   April 2011
6. KONTOS S , Papatsoris A, Kominea A, Melachrinou M, et al
   Expression of ERbeta and Its Co-Regulators p300 and NCoR in Human Transitional Cell Bladder Cancer.
   Urol Int. 2011.
   PubMed     Text format     Related articles   
   
   
   
   February 2011
7. LIN HY , Huang CH, Yu TJ, Wu WJ, et al
   p53 Codon 72 Polymorphism Was Associated with Vulnerability, Progression, but Not Prognosis of Bladder Cancer in a Taiwanese Population: An Implication of Structural Equation Modeling to Manage the Risks of Bladder Cancer.
   Urol Int. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. EKICI S , Eroglu A, Dogan Ekici AI, Turkeri L, et al
   Clusterin immunoreactivity as a predictive factor for progression of non-muscle-invasive bladder carcinoma.
   Urol Int. 2011;86:31-5.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. DE PASQUALE V , Magistrelli A, Diomedi Camassei F, Caione P, et al
   Unusual bladder mass in a 14-year-old boy: bladder paraganglioma.
   Urol Int. 2011;86:117-20.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   January 2011
10. WU D , Tao J, Xu B, Qing W, et al
    Phosphatidylinositol 3-Kinase Inhibitor LY294002 Suppresses Proliferation and Sensitizes Doxorubicin Chemotherapy in Bladder Cancer Cells.
    Urol Int. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. VIDEIRA PA , Piteira AR, Cabral MG, Martins C, et al
    Effects of Bevacizumab on Autocrine VEGF Stimulation in Bladder Cancer Cell Lines.
    Urol Int. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. ODERDA M , Ruoppolo M, Marson F, Pisano F, et al
    Pathological features and adverse prognosis of a contemporary series of neuroendocrine bladder tumours.
    Urol Int. 2011;86:185-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. PHILIPPOU P , Kariotis I, Volanis D, Ploumides A, et al
    Plasmacytoid urothelial carcinoma of the bladder: a rare malignancy.
    Urol Int. 2011;86:370-2.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. FECHNER G , Rogenhofer S, Hauser S, Muller SC, et al
    Evoluting the invaginated--one step closer to the perfect valve? Modified serosal lined tapered ileum (Kalble's procedure) as a continence mechanism for catheterizable pouches.
    Urol Int. 2011;86:269-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. GUNIA S , May M, Koch S, Erbersdobler A, et al
    Is radical oncosurgery justified for the treatment of primary malignant fibrous histiocytoma of the urinary bladder? Report of two cases and analyses of disease-specific survival rates based on a review of the literature.
    Urol Int. 2011;86:261-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. LIN Y , Sun G, Liu X, Chen Y, et al
    Clinical significance of T-cadherin tissue expression in patients with bladder transitional cell carcinoma.
    Urol Int. 2011;86:340-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. WANG J , Wang FW
    Clinical characteristics and outcomes of patients with primary signet-ring cell carcinoma of the urinary bladder.
    Urol Int. 2011;86:453-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. NUHN P , Bastian PJ, Novara G, Svatek RS, et al
    Concomitant carcinoma in situ in cystectomy specimens is not associated with clinical outcomes after surgery.
    Urol Int. 2011;87:42-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. JOVANOVIC M , Soldatovic I, Janjic A, Vuksanovic A, et al
    Diagnostic value of the nuclear matrix protein 22 test and urine cytology in upper tract urothelial tumors.
    Urol Int. 2011;87:134-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. KRUCK S , Bedke J, Hennenlotter J, Amend B, et al
    Virtual bladder tumor transurethral resection: an objective evaluation tool to overcome learning curves with and without photodynamic diagnostics.
    Urol Int. 2011;87:138-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. KRAMER MW , Waalkes S, Serth J, Hennenlotter J, et al
    Decreased galectin-8 is a strong marker for recurrence in urothelial carcinoma of the bladder.
    Urol Int. 2011;87:143-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. IDE H , Satou A, Hoshino K, Yasumizu Y, et al
    Successful management of metastatic urothelial carcinoma with gemcitabine and Paclitaxel chemotherapy in a hemodialysis patient.
    Urol Int. 2011;87:245-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. KANG SG , Kang SH, Choi H, Ko YH, et al
    Robot-assisted partial cystectomy of a bladder pheochromocytoma.
    Urol Int. 2011;87:241-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
24. GONTERO P , Oderda M, Altieri V, Bartoletti R, et al
    Are Referral Centers for Non-Muscle-Invasive Bladder Cancer Compliant to EAU Guidelines? A Report from the Vesical Antiblastic Therapy Italian Study.
    Urol Int. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
25. HA YS , Yan C, Park C, Yun SJ, et al
    GSTT1: A Marker of the Aggressiveness of Bladder Cancer.
    Urol Int. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. BIVALACQUA TJ , Loeb S, Pierorazio PM, Schoenberg MP, et al
    Is Prostate-Specific Antigen Surveillance Necessary in Men with Benign Prostate Pathology following Radical Cystoprostatectomy for Bladder Cancer?
    Urol Int. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. HOFNER T , Haferkamp A, Knapp L, Pahernik S, et al
    Preoperative Hydronephrosis Predicts Advanced Bladder Cancer but Is Not an Independent Factor for Cancer-Specific Survival after Radical Cystectomy.
    Urol Int. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
28. TOTARO A , Pinto F, Brescia A, Racioppi M, et al
    Imaging in Bladder Cancer: Present Role and Future Perspectives.
    Urol Int. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. GOOSSENS-LAAN CA , Kil PJ, Roukema JA, Bosch JL, et al
    Quality of Care Indicators for Muscle-Invasive Bladder Cancer.
    Urol Int. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
30. MIYAKE M , Fujimoto K, Anai S, Ohnishi S, et al
    Clinical Significance of Heme Oxygenase-1 Expression in Non-Muscle-Invasive Bladder Cancer.
    Urol Int. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
31. VILLAVICENCIO H , Rodriguez Faba O, Palou J, Gausa L, et al
    Bladder Preservation Strategy Based on Combined Therapy in Patients with Muscle-Invasive Bladder Cancer: Management and Results at Long-Term Follow-Up.
    Urol Int. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. MADERSBACHER S , Bauer W, Willinger M, Wehrberger C, et al
    Radical Cystectomy for Bladder Cancer in the 70+ Population: A Nation-Wide Registry Analysis of 845 Patients.
    Urol Int. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. SONG YS , Cho JS, Cho KS, Doo SH, et al
    Efficacy of adjuvant gemcitabine-cisplatin chemotherapy: a comparative study between locally advanced transitional cell carcinoma of the bladder and upper urinary tract.
    Urol Int. 2010;85:47-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
34. RACIOPPI M , Volpe A, Cappa E, D'Agostino D, et al
    Intensive Intravesical Mitomycin C Therapy in Non-Muscle-Invasive Bladder Cancer: A Dose Intensity Approach.
    Urol Int. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
35. CHLOSTA P , Drewa T, Dobruch J, Antoniewicz A, et al
    Is Pure Laparoscopic Radical Cystectomy Still an Attractive Solution for the Treatment of Muscle-Invasive Bladder Cancer?
    Urol Int. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
36. ZHANG K , Shi B, Chen J, Zhang D, et al
    Bone Marrow Mesenchymal Stem Cells Induce Angiogenesis and Promote Bladder Cancer Growth in a Rabbit Model.
    Urol Int. 2010;84:94-99.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. WANG SZ , Chen LW, Zhang YH, Wang WW, et al
    Comparison of Hand-Assisted Laparoscopic and Open Radical Cystectomy for Bladder Cancer.
    Urol Int. 2010;84:28-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. PORENA M , Del Zingaro M, Lazzeri M, Mearini L, et al
    Bacillus Calmette-Guerin versus Gemcitabine for Intravesical Therapy in High-Risk Superficial Bladder Cancer: A Randomised Prospective Study.
    Urol Int. 2010;84:23-27.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. RABBANI F , Lee C, Chang SS, Lerner SP, et al
    Accuracy of the Extent of Bladder Cancer Nodal Metastases Found at Pelvic Lymphadenectomy at the Time of Cystectomy: Relation to Primary Tumor Stage.
    Urol Int. 2010;84:14-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. KATO M , Onishi T, Hoshina A, Yabana T, et al
    Successful treatment with paclitaxel/carboplatin chemotherapy in advanced adenocarcinoma of the urinary tract producing carcinoembryonic antigen, carbohydrate antigen 19-9 and carbohydrate antigen 125.
    Urol Int. 2010;84:116-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. MOUSSA S , Yafi FA, El-Hakim A, Fahmy N, et al
    Outcome of surgical treatment of patients with upper versus lower urinary tract urothelial carcinoma: stage-by-stage comparison.
    Urol Int. 2010;84:50-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. FALEBITA OA , Lee G, Sweeney P
    Urine cytology in the evaluation of urological malignancy revisited: is it still necessary?
    Urol Int. 2010;84:45-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. KATKOORI D , Manoharan M, Araki M, Soloway MS, et al
    Role of patient-physician dialogue in selecting the type of urinary diversion.
    Urol Int. 2010;84:40-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. BOTTAI A , Li Marzi V, Alessandrini M, Villari D, et al
    Intrauterine device-associated actinomycosis of the ovary and urinary bladder: a case report.
    Urol Int. 2010;85:242-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. LIANG JF , Zheng HX, Li N, Yin Y, et al
    Fluorescent microsatellite analysis of urine sediment in patients with urothelial carcinoma.
    Urol Int. 2010;85:296-303.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. YUCEL M , Hatipoglu NK, Atakanli C, Yalcinkaya S, et al
    Is repeat transurethral resection effective and necessary in patients with T1 bladder carcinoma?
    Urol Int. 2010;85:276-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. PAN C , Wu X, Luo C, Yang S, et al
    Exon 2 methylation inhibits hepaCAM expression in transitional cell carcinoma of the bladder.
    Urol Int. 2010;85:347-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. TURKERI L , Tanidir Y, Cal C, Ozen H, et al
    Comparison of the efficacy of single or double intravesical epirubicin instillation in the early postoperative period to prevent recurrences in non-muscle-invasive urothelial carcinoma of the bladder: prospective, randomized multicenter study.
    Urol Int. 2010;85:261-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: